+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Glycobiology Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • July 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855079
The global glycobiology market was valued at USD 1.5 billion in 2022, driven by the increasing prevalence of sports injuries and orthopaedic disorders across the globe. The market size is anticipated to grow at a CAGR of 15.2% during the forecast period of 2023-2031 to achieve a value of USD 5.5 billion by 2031.

Glycobiology: Introduction

Glycobiology is a field of biology that focuses on the study of carbohydrates, also known as glycans, and their roles in various biological processes. It explores the structures, functions, and interactions of glycans with proteins, lipids, and other molecules in living organisms.

Carbohydrates are essential components of cells and play critical roles in numerous biological processes, including cell-cell communication, immune response, tissue development, and disease progression. Glycobiology seeks to understand how glycans contribute to these processes and how they can be targeted for therapeutic interventions.

Glycobiology encompasses various research areas, including glycan synthesis and modification, glycan-binding proteins (lectins), glycan-based signaling pathways, and glycan-related diseases. Researchers in this field use a range of techniques, such as mass spectrometry, nuclear magnetic resonance spectroscopy, and advanced imaging methods, to analyze and study glycans and their interactions.

Key Trends in the Glycobiology Market

Some key trends involved in the glycobiology market are as follows:
  • Glycan Profiling: There is a growing emphasis on comprehensive profiling of glycans, including their structures, compositions, and modifications. Advanced analytical techniques, such as mass spectrometry and high-performance liquid chromatography, are being used to characterize the glycome of cells, tissues, and biological fluids. This allows researchers to gain a deeper understanding of the diversity and complexity of glycans and their roles in different biological processes
  • Functional Glycomics: Glycobiology research is shifting from studying glycan structures to investigating their functional significance. This includes elucidating the roles of glycans in cell signaling, adhesion, immune response, and disease progression. Techniques such as glycan microarrays and glycan-based functional assays are being employed to identify specific glycan-protein interactions and their impact on cellular functions
  • Therapeutic Applications: The field of glycobiology is increasingly focused on harnessing the potential of glycans for therapeutic applications. This includes the development of glycan-based therapeutics, such as glycan mimetics and glycoconjugate vaccines, for the treatment and prevention of diseases. Glycans are also being explored as targets for drug development and as biomarkers for disease diagnosis and monitoring

Glycobiology Market Segmentations

Market Breakup by Product

  • Enzymes
  • Instruments
  • Reagents
  • Kits

Market Breakup by Application

  • Drug Discovery and Development
  • Disease Diagnostics
  • Virology
  • Cell Biology
  • Oncology
  • Others

Market Breakup by End User

  • Research Institutes
  • Diagnostic Centers
  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Glycobiology Market Scenario

Glycobiology, the study of glycans (carbohydrates) and their roles in biological systems, has gained significant attention and recognition in recent years. The market for glycobiology research and applications is witnessing steady growth and is expected to continue expanding in the coming years.

One of the primary drivers of the glycobiology market is the increasing understanding of the importance of glycans in various biological processes and diseases. Glycans play critical roles in cell-cell communication, immune response, protein folding and stability, and many other biological functions. As researchers uncover more about the complex interactions between glycans and proteins, there is a growing demand for tools, technologies, and expertise in glycobiology.

In summary, the glycobiology market is experiencing growth due to the increasing recognition of the significance of glycans in biology and disease, the demand for tools and technologies to study and manipulate glycans, and the potential applications of glycobiology in healthcare and pharmaceutical industries. The market is expected to continue expanding as research in glycobiology progresses and more applications are discovered.

Glycobiology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Shimadzu Corporation
  • Takara Bio Inc
  • Promega Corporation
  • Danaher Corporation
  • AMS Bio
  • Sumitomo Bakelite Co. Ltd
  • Dextra Laboratories Ltd
  • RayBiotech, Inc
  • Waters Corporation
  • Glycotope GmbH
  • New England Biolabs, Inc
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Glycobiology Market Overview
3.1 Global Glycobiology Market Historical Value (2016-2022)
3.2 Global Glycobiology Market Forecast Value (2023-2031)
4 Global Glycobiology Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Glycobiology Market Segmentation
5.1 Global Glycobiology Market by Product
5.1.1 Market Overview
5.1.2 Enzymes
5.1.3 Instruments
5.1.4 Reagents
5.1.5 Kits
5.2 Global Glycobiology Market by Application
5.2.1 Market Overview
5.2.2 Drug Discovery and Development
5.2.3 Disease Diagnostics
5.2.4 Virology
5.2.5 Cell Biology
5.2.6 Oncology
5.2.7 Others
5.3 Global Glycobiology Market by End User
5.3.1 Market Overview
5.3.2 Research Institutes
5.3.3 Diagnostic Centers
5.3.4 Hospitals
5.3.5 Clinical Laboratories
5.3.6 Pharmaceutical and Biotechnology Companies
5.3.7 Others
5.4 Global Glycobiology Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Glycobiology Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Glycobiology Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Glycobiology Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.6 Australia
8.7 Others
9 Latin America Glycobiology Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Glycobiology Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.5 Others
16 Supplier Landscape
16.1 Merck KGaA
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Thermo Fisher Scientific Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Shimadzu Corporation
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Takara Bio Inc.
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Promega Corporation
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Danaher Corporation
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 AMS Bio
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Sumitomo Bakelite Co. Ltd.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Dextra Laboratories Ltd.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 RayBiotech, Inc.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Waters Corporation
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Glycotope GmbH
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 New England Biolabs, Inc.
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
17 Global Glycobiology Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Promega Corporation
  • Danaher Corporation
  • AMS Bio
  • Sumitomo Bakelite Co. Ltd.
  • Dextra Laboratories Ltd.
  • RayBiotech, Inc.
  • Waters Corporation
  • Glycotope GmbH
  • New England Biolabs, Inc.



Table Information